The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Matrix metalloproteinases in neuroinflammation
Abstract
Matrix metalloproteinases (MMPs) are a gene family of neutral proteases that are important in normal development, wound healing, and a wide variety of pathological processes, including the spread of metastatic cancer cells, arthritic destruction of joints, atherosclerosis, and neuroinflammation. In the central nervous system (CNS), MMPs have been shown to degrade components of the basal lamina, leading to disruption of the blood‐brain barrier (BBB), and to contribute to the neuroinflammatory response in many neurological diseases. Brain cells express both constitutive and inducible MMPs in response to cellular stress. MMPs are tightly regulated to avoid unwanted proteolysis. Secreted as inactive enzymes, the MMPs require activation by other proteases and free radicals. The MMPs are part of a larger class of metalloproteinases (MPs), which includes the recently discovered ADAMs (a disintegrin and metalloproteinase domain) and ADAMTS (a disintegrin and metalloproteinase thrombospondin) families. MPs have complex roles at the cell surface and within the extracellular matrix. At the cell surface, they act as sheddases, releasing growth factors, death receptors, and death‐inducing ligands, making them important in cell survival and death. Tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors that regulate the activity of the MMPs. Synthetic inhibitors have been developed for the treatment of arthritis and cancer. These hydroxymate‐based compounds have been shown to reduce injury in experimental allergic encephalomyelitis (EAE), experimental allergic neuritis (EAN), cerebral ischemia, intracerebral hemorrhage, and viral and bacterial infections. MPs have both beneficial and detrimental roles; understanding their expression in various CNS insults will allow for the use of MMP inhibitors in the treatment of neurological disorders. GLIA 39:279–291, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Shrinkage necrosis: A distinct mode of cellular death
Kerr, J. F. R. (1971) · The Journal of Pathology · doi:10.1002/path.1711050103 · Cited by 1,454
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
Activation mechanisms of matrix metalloproteinases.
Nagase, H. (1997) · PubMed · Cited by 1,119
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004
Quantitative Zymography: Detection of Picogram Quantities of Gelatinases
Kleiner, D. E., & Stetlerstevenson, W. G. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1186 · Cited by 861
Rosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998) · Stroke · doi:10.1161/01.str.29.10.2189 · Cited by 861
Self-citationRomanic, A. M., White, R. F., Arleth, A. J., Ohlstein, E. H., & Barone, F. C. (1998) · Stroke · doi:10.1161/01.str.29.5.1020 · Cited by 739
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
Carmeliet, P., Moons, L., Lijnen, R., Baes, M., Lemaître, V., Tipping, P., Drew, A., Eeckhout, Y., Shapiro, S., Lupu, F., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-439 · Cited by 661
Matrix metalloproteinases and diseases of the CNS
Wee Yong, V., Forsyth, P. A., Bell, R., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 639
Asahi, M., Asahi, K., Jung, J.-C., del Zoppo, G. J., Fini, M. E., & Lo, E. H. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00007 · Cited by 610
Very Delayed Infarction after Mild Focal Cerebral Ischemia: A Role for Apoptosis?
Du, C., Hu, R., Csernansky, C. A., Hsu, C. Y., & Choi, D. W. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199603000-00003 · Cited by 600
Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D. L., & Quigley, J. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13066 · Cited by 591
Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
McGeehan, G. M., Becherer, J. D., Bast, R. C., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., et al. (1994) · Nature · doi:10.1038/370558a0 · Cited by 561
Schlöndorff, J., & Blobel, C. P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.21.3603 · Cited by 550
Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia
Heo, J. H., Lucero, J., Abumiya, T., Koziol, J. A., Copeland, B. R., & del Zoppo, G. J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00005 · Cited by 547
Endres, M., Namura, S., Shimizu-Sasamata, M., Waeber, C., Zhang, L., Gómez-Isla, T., Hyman, B. T., & Moskowitz, M. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199803000-00002 · Cited by 543
Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., & Werb, Z. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35860-x · Cited by 525
T cell gelatinases mediate basement membrane transmigration in vitro.
Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W., & Hauser, S. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4379 · Cited by 492
Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P., & Edwards, D. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37115-6 · Cited by 480
Programmed Cell Death in Cerebral Ischemia
Graham, S. H., & Chen, J. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200102000-00001 · Cited by 472
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., & Mignatti, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2319 · Cited by 422
Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat
Rosenberg, G. A., Navratil, M., Barone, F., & Feuerstein, G. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00002 · Cited by 403
Self-citationGasche, Y., Fujimura, M., Morita-Fujimura, Y., Copin, J.-C., Kawase, M., Massengale, J., & Chan, P. H. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199909000-00010 · Cited by 400
Gasche, Y., Copin, J.-C., Sugawara, T., Fujimura, M., & Chan, P. H. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200112000-00003 · Cited by 390
Rosenberg, G. A., Cunningham, L. A., Wallace, J., Alexander, S., Estrada, E. Y., Grossetete, M., Razhagi, A., Miller, K., & Gearing, A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03294-7 · Cited by 388
Self-citationMicrovascular Basal Lamina Antigens Disappear During Cerebral Ischemia and Reperfusion
Hamann, G. F., Okada, Y., Fitridge, R., & del Zoppo, G. J. (1995) · Stroke · doi:10.1161/01.str.26.11.2120 · Cited by 367
Kuroiwa, T., Ting, P., Martinez, H., & Klatzo, I. (1985) · Acta Neuropathologica · doi:10.1007/bf00688633 · Cited by 358
Montaner, J., Alvarez-Sabín, J., Molina, C., Anglés, A., Abilleira, S., Arenillas, J., González, M. A., & Monasterio, J. (2001) · Stroke · doi:10.1161/01.str.32.8.1759 · Cited by 350
Matrix Metalloproteinases in Cerebrovascular Disease
Mun-Bryce, S., & Rosenberg, G. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00001 · Cited by 348
Self-citationGijbels, K., Galardy, R. E., & Steinman, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117578 · Cited by 339
Lapchak, P. A., Chapman, D. F., & Zivin, J. A. (2000) · Stroke · doi:10.1161/01.str.31.12.3034 · Cited by 339
Plasminogen Activators and Matrix Metalloproteinases in Angiogenesis
Mignatti, P., & Rifkin, D. B. (1996) · Enzyme and Protein · doi:10.1159/000468621 · Cited by 330
Colbourne, F., Sutherland, G. R., & Auer, R. N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04200.1999 · Cited by 327
Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat
Rosenberg, G. A., & Navratil, M. (1997) · Neurology · doi:10.1212/wnl.48.4.921 · Cited by 305
Self-citationMontaner, J., Alvarez-Sabín, J., Molina, C. A., Anglés, A., Abilleira, S., Arenillas, J., & Monasterio, J. (2001) · Stroke · doi:10.1161/hs1201.99512 · Cited by 298
Maeda, A., & Sobel, R. A. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00005 · Cited by 291
Gijbels, K., Masure, S., Carton, H., & Opdenakker, G. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90192-n · Cited by 281
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
Rosenberg, G. A., Kornfeld, M., Estrada, E., Kelley, R. O., Liotta, L. A., & Stetler-Stevenson, W. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90681-x · Cited by 281
Self-citationRosenberg, G. A., Dencoff, J. E., Correa, N., Reiners, M., & Ford, C. C. (1996) · Neurology · doi:10.1212/wnl.46.6.1626 · Cited by 278
Self-citationA new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family.
Pavloff, N., Staskus, P. W., Kishnani, N. S., & Hawkes, S. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41928-x · Cited by 271
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
Anthony, D. C., Ferguson, B., Matyzak, M. K., Miller, K. M., Esiri, M. M., & Perry, V. H. (1997) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1997.00066.x · Cited by 268
Cuzner, M. L., & Opdenakker, G. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00241-0 · Cited by 268
Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes
Oh, L. Y. S., Larsen, P. H., Krekoski, C. A., Edwards, D. R., Donovan, F., Werb, Z., & Yong, V. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08464.1999 · Cited by 267
Rosenberg, G. A., Estrada, E. Y., Dencoff, J. E., & Stetler-Stevenson, W. G. (1995) · Brain Research · doi:10.1016/0006-8993(95)01089-0 · Cited by 261
Self-citationMatrix Metalloproteinases Contribute to Brain Damage in Experimental Pneumococcal Meningitis
Leib, S. L., Leppert, D., Clements, J., & Täuber, M. G. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.615-620.2000 · Cited by 259
Cuzner, M. L., Gveric, D., Strand, C., Loughlin, A. J., Paemen, L., Opdenakker, G., & Newcombe, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199612000-00002 · Cited by 251
Fleur, M. L., Underwood, J. L., Rappolee, D. A., & Werb, Z. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2311 · Cited by 240
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
Waubant, E., Goodkin, D. E., Gee, L., Bacchetti, P., Sloan, R., Stewart, T., Andersson, P.-B., Stabler, G., & Miller, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1397 · Cited by 234
Extracellular matrix degradation by metalloproteinases and central nervous system diseases
Lukes, A., Mun-Bryce, S., Lukes, M., & Rosenberg, G. A. (1999) · Molecular Neurobiology · doi:10.1007/bf02821717 · Cited by 230
Self-citationGelatinase B modulates selective opening of the blood-brain barrier during inflammation
Mun-Bryce, S., & Rosenberg, G. A. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.5.r1203 · Cited by 229
Self-citationLeib, S. L. (2001) · Brain · doi:10.1093/brain/124.9.1734 · Cited by 228
Matrix Metalloproteinases in Brain Injury
ROSENBERG, G. A. (1995) · Journal of Neurotrauma · doi:10.1089/neu.1995.12.833 · Cited by 218
Self-citationHerron, G. S., Werb, Z., Dwyer, K., & Banda, M. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35859-3 · Cited by 216
White matter damage is associated with matrix metalloproteinases in vascular dementia
Rosenberg, G. A., Sullivan, N., & Esiri, M. M. (2001) · Stroke · doi:10.1161/01.str.32.5.1162 · Cited by 207
Self-citationExtracellular Matrix‐Degrading Proteinases in the Nervous System
Romanic, A. M., & Madri, J. A. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00825.x · Cited by 207
Clements, J. M., Cossins, J. A., Wells, G. M. A., Corkill, D. J., Helfrich, K., Wood, L. M., Pigott, R., Stabler, G., Ward, G. A., Gearing, A. J. H., et al. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00210-x · Cited by 205
ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade
Baricos, W. H., Cortez, S. L., El-Dahr, S. S., & Schnaper, H. W. (1995) · Kidney International · doi:10.1038/ki.1995.150 · Cited by 202
Microglial cells are a component of the perivascular glia limitans
Lassmann, H., Zimprich, F., Vass, K., & Hickey, W. F. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280211 · Cited by 201
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis
Lee, M. A., Palace, J., Stabler, G., Ford, J., Gearing, A., & Miller, K. (1999) · Brain · doi:10.1093/brain/122.2.191 · Cited by 199
Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium
Harkness, K. A. (2000) · Brain · doi:10.1093/brain/123.4.698 · Cited by 195
Gottschall, P. E., & Yu, X. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041513.x · Cited by 192
Smith, M. R., Kung, H.-F., Durum, S. K., Colburn, N. H., & Sun, Y. (1997) · Cytokine · doi:10.1006/cyto.1997.0233 · Cited by 188
Apodaca, G., Rutka, J., Bouhana, K., Berens, M. E., Giblin, J. R., Rosenblum, M. L., McKerrow, J. H., & Banda, M. J. (1990) · PubMed · Cited by 178
Deb, S., & Gottschall, P. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041641.x · Cited by 163
Guédez, L., Courtemanch, L., & Stetler‐Stevenson, M. (1998) · Blood · doi:10.1182/blood.v92.4.1342 · Cited by 154
Hewson, A. K., Smith, T., Leonard, J. P., & Cuzner, M. L. (1995) · Inflammation Research · doi:10.1007/bf01796266 · Cited by 144
Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors
Liedtke, W., Cannella, B., Mazzaccaro, R. J., Clements, J. M., Miller, K., Wucherpfenning, K. W., Gearing, A. J. H., & Raine, C. S. (1998) · Annals of Neurology · doi:10.1002/ana.410440110 · Cited by 128
Galboiz, Y., Shapiro, S., Lahat, N., Rawashdeh, H., & Miller, A. (2001) · Annals of Neurology · doi:10.1002/ana.1218 · Cited by 125
Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS
Trojano, M., Avolio, C., Liuzzi, G. M., Ruggieri, M., Defazio, G., Liguori, M., Santacroce, M. P., Paolicelli, D., Giuliani, F., Riccio, P., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1402 · Cited by 125
Rudolph‐Owen, L. A., Hulboy, D. L., Wilson, C. L., Mudgett, J. S., & Matrisian, L. M. (1997) · Endocrinology · doi:10.1210/en.138.11.4902 · Cited by 121
Lemons, M. L., Sandy, J. D., Anderson, D. K., & Howland, D. R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04772.2001 · Cited by 100
Leppert, D., Hughes, P., Huber, S., Erne, B., Grygar, C., Saïd, G., Miller, K., Steck, A. J., Probst, A., & Fuhr, P. (1999) · Neurology · doi:10.1212/wnl.53.1.62 · Cited by 99
Protease production by cultured microglia: Substrate gel analysis and immobilized matrix degradation
Colton, C. A., Keri, J. E., Chen, W. T., & Monsky, W. L. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350309 · Cited by 84
Vos, C. M. P., Sjulson, L., Nath, A., McArthur, J. C., Pardo, C. A., Rothstein, J. D., & Conant, K. E. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7388 · Cited by 84
The inflammatory response in the CNS
Perry, V. H., & Andersson, P.-B. (1992) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1992.tb00811.x · Cited by 84
Redford, E. J. (1997) · Brain · doi:10.1093/brain/120.10.1895 · Cited by 84
Matrix metalloproteinase expression during experimental autoimmune neuritis
Hughes, P. (1998) · Brain · doi:10.1093/brain/121.3.481 · Cited by 82
Wells, G., Catlin, G., Cossins, J. A., Mangan, M., Ward, G. A., Miller, K., & Clements, J. M. (1996) · Glia · Cited by 68
Stromelysin-1 and gelatinase A are upregulated before TNF-α in LPS-stimulated neuroinflammation
Mun-Bryce, S., Lukes, A., Wallace, J. A., Lukes-Marx, M., & Rosenberg, G. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02303-x · Cited by 67
Self-citationWang, X., Barone, F. C., White, R. F., et al. (1998) · Stroke · doi:10.1161/01.str.29.2.516 · Cited by 58
Loging, W., & Reisman, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203135 · Cited by 41
Bian, J., Jacobs, C., Wang, Y., & Sun, Y. (1996) · Carcinogenesis · doi:10.1093/carcin/17.12.2559 · Cited by 21
Matrix metalloproteinases in multiple sclerosis: Is it time for a treatment trial?
Rosenberg, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.1236 · Cited by 20
Self-citation
Cited by
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722
Self-citationNeuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Self-citationThe inflammatory response in stroke
Wang, Q., Tang, X. N., & Yenari, M. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.014 · Cited by 1,177
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Metadata
- Authors
- Rosenberg, G. A.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2002-07-18
- Volume
- 39
- Issue
- 3
- Pages
- 279-291
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W1998557118
- Cited by
- 868
- References
- 93
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.